<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38532547</PMID><DateCompleted><Year>2024</Year><Month>03</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2164-554X</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Dec</Month><Day>31</Day></PubDate></JournalIssue><Title>Human vaccines &amp; immunotherapeutics</Title><ISOAbbreviation>Hum Vaccin Immunother</ISOAbbreviation></Journal><ArticleTitle>COVID-19 vaccination perspectives among patients with Long COVID: A qualitative study.</ArticleTitle><Pagination><StartPage>2327663</StartPage><MedlinePgn>2327663</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">2327663</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1080/21645515.2024.2327663</ELocationID><Abstract><AbstractText>Individuals who have Long COVID may have unique perspectives about COVID-19 vaccination due to the significant impact that COVID-19 has had on their lives. However, little is known about the specific vaccination perspectives among this patient population. The goal of our study was to improve our understanding of perspectives about COVID-19 vaccines among individuals with Long COVID. Interviews were conducted with patients receiving care at a post-COVID recovery clinic. Deductive thematic analysis was used to characterize participant perspectives according to the vaccine acceptance continuum framework, which recognizes a spectrum from vaccine acceptance to refusal. From interviews with 21 patients, we identified perspectives across the continuum of vaccine acceptance. These perspectives included acceptance of vaccines to prevent future illness, concerns about vaccine side effects on Long COVID symptoms, and refusal of vaccines due to perceived natural immunity. A limitation of our study is that these perspectives are specific to individuals receiving care at one post-COVID recovery clinic. In conclusion, our study demonstrates that some patients with Long COVID are uncertain about COVID-19 vaccines and boosters but may also be amenable to conversations that impact future vaccination acceptance. Patient perspectives should be considered when communicating recommendations for COVID-19 vaccinations to this population.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>MacEwan</LastName><ForeName>Sarah R</ForeName><Initials>SR</Initials><Identifier Source="ORCID">0000-0002-4365-6232</Identifier><AffiliationInfo><Affiliation>Division of General Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for the Advancement of Team Science, Analytics, and Systems Thinking in Health Services and Implementation Science Research (CATALYST), The Ohio State University, Columbus, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rahurkar</LastName><ForeName>Saurabh</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center for the Advancement of Team Science, Analytics, and Systems Thinking in Health Services and Implementation Science Research (CATALYST), The Ohio State University, Columbus, OH, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, College of Medicine, The Ohio State University, Columbus, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tarver</LastName><ForeName>Willi L</ForeName><Initials>WL</Initials><AffiliationInfo><Affiliation>Center for the Advancement of Team Science, Analytics, and Systems Thinking in Health Services and Implementation Science Research (CATALYST), The Ohio State University, Columbus, OH, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cancer Prevention and Control, The Ohio State University, Columbus, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gaughan</LastName><ForeName>Alice A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Center for the Advancement of Team Science, Analytics, and Systems Thinking in Health Services and Implementation Science Research (CATALYST), The Ohio State University, Columbus, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rush</LastName><ForeName>Laura J</ForeName><Initials>LJ</Initials><AffiliationInfo><Affiliation>Center for the Advancement of Team Science, Analytics, and Systems Thinking in Health Services and Implementation Science Research (CATALYST), The Ohio State University, Columbus, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schamess</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of General Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McAlearney</LastName><ForeName>Ann Scheck</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Center for the Advancement of Team Science, Analytics, and Systems Thinking in Health Services and Implementation Science Research (CATALYST), The Ohio State University, Columbus, OH, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Family and Community Medicine, College of Medicine, The Ohio State University, Columbus, OH, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U54 CA260582</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Hum Vaccin Immunother</MedlineTA><NlmUniqueID>101572652</NlmUniqueID><ISSNLinking>2164-5515</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="Y">COVID-19 Vaccines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007117" MajorTopicYN="N">Immunization, Secondary</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Post-acute COVID-19 syndrome</Keyword><Keyword MajorTopicYN="N">booster</Keyword><Keyword MajorTopicYN="N">qualitative research</Keyword><Keyword MajorTopicYN="N">vaccination</Keyword></KeywordList><CoiStatement>No potential conflict of interest was reported by the author(s).</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>28</Day><Hour>6</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>27</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>27</Day><Hour>1</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>3</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38532547</ArticleId><ArticleId IdType="pmc">PMC10978020</ArticleId><ArticleId IdType="doi">10.1080/21645515.2024.2327663</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Stein C, Nassereldine H, Sorensen RJD, Amlag JO, Bisignano C, Byrne S, Castro E, Coberly K, Collins JK, Dalos J, et al. Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis. Lancet. 2023;401(10379):833&#x2013;6. doi:10.1016/S0140-6736(22)02465-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)02465-5</ArticleId><ArticleId IdType="pmc">PMC9998097</ArticleId><ArticleId IdType="pubmed">36930674</ArticleId></ArticleIdList></Reference><Reference><Citation>Bobrovitz N, Ware H, Ma X, Li Z, Hosseini R, Cao C, Selemon A, Whelan M, Premji Z, Issa H, et al. Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression. Lancet Infect Dis. 2023;23(5):556&#x2013;567. doi:10.1016/S1473-3099(22)00801-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(22)00801-5</ArticleId><ArticleId IdType="pmc">PMC10014083</ArticleId><ArticleId IdType="pubmed">36681084</ArticleId></ArticleIdList></Reference><Reference><Citation>Spinardi JR, Srivastava A.. Hybrid immunity to SARS-CoV-2 from infection and vaccination-evidence synthesis and implications for new COVID-19 vaccines. Biomedicines. 2023;11(2):370. doi:10.3390/biomedicines11020370.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines11020370</ArticleId><ArticleId IdType="pmc">PMC9953148</ArticleId><ArticleId IdType="pubmed">36830907</ArticleId></ArticleIdList></Reference><Reference><Citation>Freeman D, Loe BS, Chadwick A, Vaccari C, Waite F, Rosebrock L, Jenner L, Petit A, Lewandowsky S, Vanderslott S, et al. COVID-19 vaccine hesitancy in the UK: the Oxford coronavirus explanations, attitudes, and narratives survey (Oceans) II. Psychol Med. 2022;52(14):3127&#x2013;3141. doi:10.1017/S0033291720005188.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0033291720005188</ArticleId><ArticleId IdType="pmc">PMC7804077</ArticleId><ArticleId IdType="pubmed">33305716</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention . COVID-19 vaccinations in the United States; 2023.  [2023 Oct 5]. https://covid.cdc.gov/covid-data-tracker/#vaccinations.</Citation></Reference><Reference><Citation>Leask J. Target the fence-sitters. Nature. 2011;473(7348):443&#x2013;445. doi:10.1038/473443a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/473443a</ArticleId><ArticleId IdType="pubmed">21614055</ArticleId></ArticleIdList></Reference><Reference><Citation>Rughini&#x219; C, Vulpe SN, Flaherty MG, Vasile S. Shades of doubt: measuring and classifying vaccination confidence in Europe. Vaccine. 2022;40(46):6670&#x2013;6679. doi:10.1016/j.vaccine.2022.09.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2022.09.039</ArticleId><ArticleId IdType="pubmed">36216651</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwok KO, Li KK, Leung CLK, Tang A, Chan EYY, Tsoi MTF, Wei WI, McNeil EB, Wong SYS. The way forward to achieve high COVID-19 vaccination and revaccination coverage in a city amid a period of tranquility. Front Public Health. 2022;10:935243. doi:10.3389/fpubh.2022.935243.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.935243</ArticleId><ArticleId IdType="pmc">PMC9515959</ArticleId><ArticleId IdType="pubmed">36187671</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, Pujol JC, Klaser K, Antonelli M, Canas LS, et al. Attributes and predictors of long COVID. Nat Med. 2021;27(4):626&#x2013;631. doi:10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyake E, Martin S. Long Covid: online patient narratives, public health communication and vaccine hesitancy. Digit Health. 2021;7:20552076211059649. doi:10.1177/20552076211059649.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20552076211059649</ArticleId><ArticleId IdType="pmc">PMC8638072</ArticleId><ArticleId IdType="pubmed">34868622</ArticleId></ArticleIdList></Reference><Reference><Citation>Dell&#x2019;imperio SG, Aboul-Hassan D, Batchelor R, Chambers-Peeple K, Clauw DJ, DeJonckheere M, Bergmans RS. Vaccine perceptions among black adults with long COVID. Ethn Health. 2023;28(6):853&#x2013;873. doi:10.1080/13557858.2023.2191914.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13557858.2023.2191914</ArticleId><ArticleId IdType="pmc">PMC10524107</ArticleId><ArticleId IdType="pubmed">37005013</ArticleId></ArticleIdList></Reference><Reference><Citation>Duradoni M, Gursesli MC, Materassi L, Serritella E, Guazzini A. The long-COVID experience changed people&#x2019;s vaccine hesitancy but not their vaccination fear. Int J Environ Res Public Health. 2022;19(21):14550. doi:10.3390/ijerph192114550.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph192114550</ArticleId><ArticleId IdType="pmc">PMC9654193</ArticleId><ArticleId IdType="pubmed">36361430</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133&#x2013;146. doi:10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>MacEwan SR, Rahurkar S, Tarver WL, Forward C, Eramo JL, Teuschler L, Gaughan AA, Rush LJ, Stanwick S, McConnell E, et al. Patient experiences navigating care coordination for Long COVID: a qualitative study. J Gen Intern Med. 2024. Epub ahead of print. doi:10.1007/s11606-024-08622-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-024-08622-z</ArticleId><ArticleId IdType="pmc">PMC11169119</ArticleId><ArticleId IdType="pubmed">38308155</ArticleId></ArticleIdList></Reference><Reference><Citation>Terry G, Hayfield N, Clarke V, Braun V. Thematic analysis. In: Willig C and Rogers WS, editors. The SAGE handbook of qualitative research in psychology. 2nd ed. 2017. p. 17&#x2013;37. London: Sage Publications Ltd.</Citation></Reference><Reference><Citation>Dub&#xe9; E, MacDonald NE. COVID-19 vaccine hesitancy. Nat Rev Nephrol. 2022;18(7):409&#x2013;10. doi:10.1038/s41581-022-00571-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41581-022-00571-2</ArticleId><ArticleId IdType="pmc">PMC9004449</ArticleId><ArticleId IdType="pubmed">35414006</ArticleId></ArticleIdList></Reference><Reference><Citation>MacDonald NE, SAGE Working Group on Vaccine Hesitancy . Vaccine hesitancy: definition, scope and determinants. Vaccine. 2015;33(34):4161&#x2013;4. doi:10.1016/j.vaccine.2015.04.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2015.04.036</ArticleId><ArticleId IdType="pubmed">25896383</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore R, Purvis RS, Willis DE, Worley KC, Hervey D, Reece S, Yeates A, McElfish PA. The vaccine hesitancy continuum among hesitant adopters of the COVID-19 vaccine. Clin Transl Sci. 2022;15(12):2844&#x2013;2857. doi:10.1111/cts.13385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cts.13385</ArticleId><ArticleId IdType="pmc">PMC9747130</ArticleId><ArticleId IdType="pubmed">36330587</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett NG, Bloom DE, Ferranna M, Kadelka C. Factors underlying COVID-19 vaccine and booster hesitancy and refusal, and incentivizing vaccine adoption. PLoS One. 2022;17(9):e0274529. doi:10.1371/journal.pone.0274529.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0274529</ArticleId><ArticleId IdType="pmc">PMC9498968</ArticleId><ArticleId IdType="pubmed">36136997</ArticleId></ArticleIdList></Reference><Reference><Citation>Oyungerel B, Paulina S, Justin C, Kylie A, Paul G. Effect of COVID-19 vaccination on long covid: systematic review. BMJ Med. 2023;2(1):e000385. doi:10.1136/bmjmed-2022-000385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjmed-2022-000385</ArticleId><ArticleId IdType="pmc">PMC9978692</ArticleId><ArticleId IdType="pubmed">36936268</ArticleId></ArticleIdList></Reference><Reference><Citation>Viet-Thi T, Elodie P, Julia S, Isabelle P, Philippe R. Efficacy of first dose of COVID-19 vaccine versus no vaccination on symptoms of patients with long covid: target trial emulation based on ComPaRe e-cohort. BMJ Med. 2023;2(1):e000229. doi:10.1136/bmjmed-2022-000229.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjmed-2022-000229</ArticleId><ArticleId IdType="pmc">PMC9978748</ArticleId><ArticleId IdType="pubmed">36910458</ArticleId></ArticleIdList></Reference><Reference><Citation>Marra AR, Kobayashi T, Callado GY, Pardo I, Gutfreund MC, Hsieh MK, Lin V, Alsuhaibani M, Hasegawa S, Tholany J, et al. The effectiveness of COVID-19 vaccine in the prevention of post-COVID conditions: a systematic literature review and meta-analysis of the latest research. Antimicrob Steward Healthc Epidemiol. 2023;3(1):e168. doi:10.1017/ash.2023.447.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/ash.2023.447</ArticleId><ArticleId IdType="pmc">PMC10644173</ArticleId><ArticleId IdType="pubmed">38028898</ArticleId></ArticleIdList></Reference><Reference><Citation>Nayyerabadi M, Fourcade L, Joshi SA, Chandrasekaran P, Chakravarti A, Mass&#xe9; C, Paul M-L, Houle J, Boubekeur AM, DuSablon C, et al. Vaccination after developing long COVID: impact on clinical presentation, viral persistence, and immune responses. Int J Infect Dis. 2023;136:136&#x2013;145. doi:10.1016/j.ijid.2023.09.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2023.09.006</ArticleId><ArticleId IdType="pubmed">37717649</ArticleId></ArticleIdList></Reference><Reference><Citation>National Center for Health Statistics . U.S. Census Bureau, household pulse survey, 2022&#x2013;2023. Long COVID; 2023.  [2023 Oct 3]. https://www.cdc.gov/nchs/covid19/pulse/long-covid.htm.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>